COPD management: Role of symptom assessment in routine clinical practice

International Journal of COPD

Volumn 8, Issue , 2013, Pages 461-471

  van der Molen, Thys ^a   Miravitlles, Marc ^b   Kocks, Janwillem W H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Questionnaires; Symptoms

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; PHOSPHODIESTERASE IV INHIBITOR;

BRONCHIECTASIS; CHEST TIGHTNESS; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COPD QUESTIONNAIRE; COPD ASSESSMENT TEST; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HUMAN; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; PRIMARY MEDICAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SPUTUM; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM ASSESSMENT; WHEEZING;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; QUESTIONNAIRES; SYMPTOMS;

COST OF ILLNESS; DYSPNEA; HUMANS; LUNG; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84885922557     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S49392     Document Type: Review

References (73)

1. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
2. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880-887.
3. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654.
4. Tsiligianni IG, van der Molen T, Moraitaki D, et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med. 2012;12:20.
5. Global Initiative for Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2011). Available from: http://www.goldcopd.com. Accessed July 25, 2013.
6. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416-469.
7. Kaplan A, Marciniuk D, Bouchard J, Tessier L. Patient symptoms dictate how physicians behave in the early diagnosis of COPD. Prim Care Respir J. 2011;20(2):A6.
8. Kornmann O, Beeh KM, Beier J, et al. Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration. 2003;70(1):67-75.
9. Barnett M. Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences. J Clin Nurs. 2005;14(7): 805-812.
10. O'Donnell D. Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance. Eur Respir Rev. 2006;15: 42-46.
11. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007;24(3):217-223.
12. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD International Survey. Eur Respir J. 2002;20(4): 799-805.
13. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116(6):1632-1637.
14. Mahler DA, Faryniarz K, Tomlinson D, et al. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest. 1992;102(2):395-401.
15. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2005;2(4):183-191.
16. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
17. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975-981.
18. Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697-709.
19. Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264-272.
20. Miravitlles M. Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med. 2011;105(8): 1118-1128.
21. Witek TJ Jr, Mahler DA. Minimal important difference of the Transition Dyspnoea Index in a multinational clinical trial. Eur Respir J. 2003;21(2):267-272.
22. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6): 532-555.
23. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586.
24. Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J. 2008;31(3):667-677.
25. Polley L, Yaman N, Heaney L, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest. 2008;134(2):295-302.
26. Agusti AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347-360.
27. Cooper CB. Airflow obstruction and exercise. Respir Med. 2009;103(3): 325-334.
28. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33(2):262-272.
29. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972-977.
30. Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119(10 Suppl 1):32-37.
31. ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD. 2007;4(3):293-297.
32. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772-778.
33. Kocks JW, Asijee GM, Tsiligianni IG, Kerstjens HA, van der Molen T. Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J. 2011;20(3): 269-275.
34. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129(3):536-544.
35. Gilbert C, Martin ML, Hareendran A. Capturing individual variation in the experience of symptoms reported by patients with COPD. Am J Respir Crit Care Med. 2007;175:A15-A1004.
36. Espinosa de los Monteros MJ, Pena C, Soto Hurtado EJ, Jareno J, Miravitlles M. Variability of respiratory symptoms in severe COPD. Arch Bronconeumol. 2012;48(1):3-7.
37. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an Internet survey. Curr Med Res Opin. 2009;25(8):2043-2048.
38. Cormick W, Olson LG, Hensley MJ, Saunders NA. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax. 1986;41(11):846-854.
39. Scharf SM, Maimon N, Simon-Tuval T, et al. Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:1-12.
40. Omachi TA, Blanc PD, Claman DM, et al. Disturbed sleep among COPD patients is longitudinally associated with mortality and adverse COPD outcomes. Sleep Med. 2012;13(5):476-483.
41. Jones PW. Issues concerning health-related quality of life in COPD. Chest. 1995;107(Suppl 5):187S-193S.
42. Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289-296.
43. Montes de Oca M, Talamo C, Halbert RJ, et al. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med. 2009;103(9):1376-1382.
44. Cruse MA. The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: a patient's perspective. COPD. 2007;4(3):279-281.
45. Gruffydd-Jones K, Marsden HC, Holmes S, et al. Utility of COPD Assessment Test (CAT) in primary care consultations: a randomised controlled trial. Prim Care Respir J. 2013;22(1):37-43.
46. Postma D, Anzueto A, Calverley P, et al. A new perspective on optimal care for patients with COPD. Prim Care Respir J. 2011;20(2): 205-209.
47. Bridevaux PO, Gerbase MW, Probst-Hensch NM, et al. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008;63(9):768-774.
48. Jacobsen R, Frolich A, Godtfredsen NS. Impact of exercise capacity on dyspnea and health-related quality of life in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2012;32(2): 92-100.
49. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434-1440.
50. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6): 1321-1327.
51. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586.
52. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. BMJ. 1978;2(6132):241-243.
53. Haughney J, Gruffydd-Jones K. Patient-centred outcomes in primary care management of C. Prim Care Respir J. 2004;13(4):185-197.
54. Ries AL. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2006;119(10 Suppl 1):12-20.
55. Kocks JW, Kerstjens HA, Snijders SL, et al. Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes. 2010;8:135.
56. Reda AA, Kotz D, Kocks JW, Wesseling G, van Schayck CP. Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med. 2010;104(11):1675-1682.
57. Kocks JW, van den Berg JW, Kerstjens HA, et al. Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:273-286.
58. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35.
59. Dodd JW, Hogg L, Nolan J, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 2011;66(5):425-429.
60. Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest. 2012;142(1):134-140.
61. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD. 2012;9(1):12-15.
62. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-415.
63. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002;19(3): 398-404.
64. de Torres JP, Pinto-Plata V, Ingenito E, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4):1092-1098.
65. Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62.
66. Kocks JW, Tsiligianni IG, van der Molen T. Responsiveness of the COPD assessment test: the minimal clinically important difference does matter. Chest. 2012;142(1):267-268.
67. Monz BU, Sachs P, McDonald J, et al. Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis. Respir Med. 2010;104(4):534-541.
68. Partridge MR, Miravitlles M, Stahl E, et al. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J. 2010;36(1):96-104.
69. Miravitlles M, Iriberri M, Barrueco M, et al. Usefulness of the LCOPD, CAFS and CASIS scales in understanding the impact of COPD on patients. Respiration. October 2, 2012. [Epub ahead of print.]
70. Miravitlles M, Soler-Cataluna JJ, Calle M, et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2012;48(7):247-257.
71. Miravitlles M, Jose Soler-Cataluna J, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes. Putting old evidence into clinical practice. Eur Respir J. 2013;41(6):1252-1256.
72. Metting EI, Riemersma RA, Sanderman R, van der Molen T, Kocks JW. Description of a Dutch well-established asthma/COPD service for primary care. Prim Care Respir J. 2013;22:A1-A18.
73. Lucas AE, Smeenk FJ, van den Borne BE, Smeele IJ, van Schayck CP. Diagnostic assessments of spirometry and medical history data by respiratory specialists supporting primary care: are they reliable? Prim Care Respir J. 2009;18(3):177-184.